99 related articles for article (PubMed ID: 21035741)
1. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy.
Khodayari-Rostamabad A; Hasey GM; Maccrimmon DJ; Reilly JP; de Bruin H
Clin Neurophysiol; 2010 Dec; 121(12):1998-2006. PubMed ID: 21035741
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
Gross A; Joutsiniemi SL; Rimon R; Appelberg B
Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
[TBL] [Abstract][Full Text] [Related]
4. [Clinical follow-up -- EEG -- serum determinations: therapeutic experience with clozapine].
Gekiere F; Dessalles MC; Poisson N; Maitre L
Encephale; 1996 Dec; 22 Spec No 6():16-23. PubMed ID: 9102314
[TBL] [Abstract][Full Text] [Related]
5. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy.
Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A
Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349
[TBL] [Abstract][Full Text] [Related]
6. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.
Chanpattana W; Sackeim HA
J ECT; 2010 Dec; 26(4):289-98. PubMed ID: 20375701
[TBL] [Abstract][Full Text] [Related]
7. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
[TBL] [Abstract][Full Text] [Related]
8. Seizure activity in combined clozapine and ECT: a retrospective view.
Cardwell BA; Nakai B
Convuls Ther; 1995 Jun; 11(2):110-3. PubMed ID: 7552049
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
Taylor DM; Smith L
Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
[TBL] [Abstract][Full Text] [Related]
12. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
13. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
Henderson DC; Goff DC
J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
[TBL] [Abstract][Full Text] [Related]
14. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
Freudenreich O; Weiner RD; McEvoy JP
Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
[TBL] [Abstract][Full Text] [Related]
15. Results of the long term treatment with clozapine. Clinical and electroencephalographic study.
Zapletálek M; Hanus H; Kucera V; Kuba M
Act Nerv Super (Praha); 1989 Apr; 31(1):36-7. PubMed ID: 2571221
[No Abstract] [Full Text] [Related]
16. Effects of clozapine on smoking in chronic schizophrenic outpatients.
George TP; Sernyak MJ; Ziedonis DM; Woods SW
J Clin Psychiatry; 1995 Aug; 56(8):344-6. PubMed ID: 7635849
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
[TBL] [Abstract][Full Text] [Related]
18. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
[TBL] [Abstract][Full Text] [Related]
19. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
Mattes JA
J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
[TBL] [Abstract][Full Text] [Related]
20. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
